This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: A patient admitted to the hospital has been using phenylephrine nasal spray (Neo-Synephrine), 2 ... (Read 56 times)

Bernana

  • Hero Member
  • *****
  • Posts: 530
on: Jul 23, 2018
A patient admitted to the hospital has been using phenylephrine nasal spray (Neo-Synephrine), 2 sprays every 4 hours, for a week.
 
  The patient complains that the medication is not working, because the nasal congestion has increased. What will the nurse do?
  a. Request an order for an oral decongestant to replace the intranasal phenylephrine.
  b. Request an order for an intranasal glucocorticoid to be used while the phenylephrine is withdrawn.
  c. Tell the patient to increase the dose of phenylephrine to 4 sprays every 4 hours.
  d. Tell the patient to stop using the phenylephrine and begin using an intranasal antihistamine.

Question 2

A patient with allergic rhinitis is taking a compound product of loratadine/pseudoephedrine (Claritin-D) every 12 hours. The patient complains of insomnia. The nurse notes that the patient is restless and anxious.
 
  The patient's heart rate is 90 beats per minute, and the blood pressure is 130/85 mm Hg. The nurse will contact the provider to:
  a. discuss using an intranasal glucocorticoid and loratadine (Claritin).
  b. report acute toxicity caused by pseudoephedrine.
  c. suggest using an agent with a sympathomimetic drug only.
  d. suggest using a topical decongestant to minimize systemic symptoms.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

234sdffa

  • Sr. Member
  • ****
  • Posts: 341
Reply #1 on: Jul 23, 2018
Answer to Question 1

ANS: B
This patient is experiencing rebound congestion, which develops when topical sympathomimetics are used for longer than a few days. Abrupt withdrawal can stop the cycle of rebound congestion but is uncomfortable, so using an intranasal glucocorticoid while withdrawing the decongestant is recommended. An oral decongestant is not recommended. Increasing the dose of the intranasal decongestant will only compound the problem of rebound congestion. Stopping the intranasal decongestant will only increase the congestion; using an intranasal antihistamine will not help with congestion.

Answer to Question 2

ANS: A
This patient is showing central nervous system (CNS) and cardiovascular side effects of the pseudoephedrine. A better option would be to use single-ingredient products for each symptom; an intranasal glucocorticoids and an oral antihistamine are considered first-line treatments. This patient is demonstrating adverse effects but not acute toxicity. Using a sympathomimetic agent would increase the adverse effects, because pseudoephedrine is a sympathomimetic drug. Topical decongestants are not first-line drugs for allergic rhinitis.


Bernana

  • Member
  • Posts: 530
Reply 2 on: Jul 23, 2018
:D TYSM

apple

  • Member
  • Posts: 352
Reply 3 on: Yesterday
Great answer, keep it coming :)

« previous next »
 

Did you know?

Dogs have been used in studies to detect various cancers in human subjects. They have been trained to sniff breath samples from humans that were collected by having them breathe into special tubes. These people included 55 lung cancer patients, 31 breast cancer patients, and 83 cancer-free patients. The dogs detected 54 of the 55 lung cancer patients as having cancer, detected 28 of the 31 breast cancer patients, and gave only three false-positive results (detecting cancer in people who didn't have it).

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Example of problem focused patient Example of problem focused patient
Patient health history form Cont. Patient health history form Cont.
Patient Teaching Methods Cont. Patient Teaching Methods Cont.
Patient with osteoarthritis. Patient with osteoarthritis.
Patient with rheumatoid arthritis. Patient with rheumatoid arthritis.
This patient presented with a case of facial palsy caused by an infection by the bacterial ... This patient presented with a case of facial palsy caused by an infection by the bacterial ...
Video: ACTH/Cortisol (glycogenolysis, protein catabolism, lipolysis and gluconeogenesis)

For a complete list of videos, visit our video library